Clinical trial
Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-041)
NCT00393354 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00393354 |
|---|---|
| Title | Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-041) |
| Official title | A Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Trial to Assess the Efficacy and Safety of MK0663 in Patients With Chronic Low Back Pain |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Recurrent Low Back Pain |
| Intervention type | Drug |
| Interventions | MK0663, Etoricoxib / Duration of Treatment : 12 Weeks, Comparator : placebo (unspecified) /Duration of Treatment : 12 Weeks |
| Enrollment | 325 |
| Start date | Apr 1, 2000 |
| Primary completion | Nov 1, 2000 |
| Completion | Nov 1, 2000 |
| First posted | Oct 27, 2006 |
| Last update posted | Feb 18, 2022 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: